Michael Quante

17PUBLICATIONS
62CO-AUTHORS
Medical infection agents (incl. prions)Respiratory diseasesCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 27, 2026
Correction: Maurer et al. Gut Microbial Disruption in Critically Ill Patients with COVID-19-Associated Pulmonary Aspergillosis. J. Fungi 2022, 8, 1265.

|Jan 09, 2026
Gastrin for the treatment of acute graft-versus-host disease of the stomach.

Jana Gawron, Marie Czech, Tamina Rückert

|May 14, 2025
Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of esophageal adenocarcinoma.

Melissa Barroux, Jacob Househam, Eszter Lakatos

|Nov 08, 2024
Targeting c-MET for Endoscopic Detection of Dysplastic Lesions within Barrett's Esophagus Using EMI-137 Fluorescence Imaging.

Yi-Jhih Huang, Jonas Rieder, Kel Vin Tan

|Oct 01, 2024
p53 mutation biases squamocolumnar junction progenitor cells towards dysplasia rather than metaplasia in Barrett's oesophagus.

Guodong Lian, Ermanno Malagola, Chengguo Wei

|Apr 08, 2024
Association Between Body Composition and Survival in Patients With Gastroesophageal Adenocarcinoma: An Automated Deep Learning Approach.

Matthias Jung, Thierno D Diallo, Tobias Scheef

Pageof 3

Frequent Collaborators

4 joint publications

Katja Steiger

3 joint publications

Klaus-Peter Janssen

3 joint publications

Ulrike Protzer

2 joint publications

Benny Chain